Erickson, Nicole http://orcid.org/0000-0002-0473-7689
Schinkoethe, T.
Eckhardt, C.
Storck, L.
Joos, A.
Liu, L.
Ballmer, P. E.
Mumm, F.
Fey, T.
Heinemann, V.
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
Article History
Received: 19 January 2021
Accepted: 8 June 2021
First Online: 22 June 2021
Declarations
:
: The methodology and all questionnaires utilized in this study were approved by the Human Research Ethics committee of the Ludwig Maximillian University of Munich in Germany and the Cantonal Ethics Committee Zurich, Switzerland (Reference number LMU19-954).
: Informed consent was obtained from all individual participants included in the study.
: L. Liu acknowledges the support of China Scholarship Council (No. 201908080031). T. Schinköthe is owner and Managing Director of CANKADO and owns stock in the company. N. Erickson has received honoraria for participating in symposia for CSL Behring, Fresenius, Baxter, Havas Lynx Group, Nutricia and GHD. V. Heinemann has received honoraria for participating in symposia and advisory boards for Merck, Amgen, Roche, Sanofi, Boehringer Ingelheim, Celgene, Sirtex Medical, Baxalta, SERVIER, Halozyme, MSD, Bristol-Myers Squibb, MSD Oncology, Lilly and Taiho Pharmaceutical. He has also received research funding from Amgen, Roche, Merck, Celgene, Boehringer Ingelheim, Sirtex Medical, Shire and Servier and travel support from Merck, Roche, Sirtex Medical, Amgen, SERVIER, Shire, MSD and Bristol-Myers Squibb. None of these activities were related to the content of this article. All remaining authors declared no conflicts of interest.